The US government has ordered 20 million doses of a vaccine that should protect eczema patients from smallpox without exposing them to the risk of developing eczema vaccinatum, a life-threatening infection, according to a press release by the vaccine’s manufacturer, the Danish biotechnology company Bavarian Nordic.
This means that, in the event of a smallpox bioterror attack, instead of relying on the dubious security of herd immunity, people like you and me can get vaccinated. Until the advent of this new vaccine, we could not.
Eczema vaccinatum made the headlines in 2007 when an
